Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
The Hospital for Sick Children Canadian Institutes of Health Research (CIHR) |
---|---|
Information provided by: | The Hospital for Sick Children |
ClinicalTrials.gov Identifier: | NCT00519207 |
The objective of this study is to determine the relative efficacy of sucrose, liposomal lidocaine, and sucrose plus liposomal lidocaine, on reducing pain during venipuncture in newborn infants.
Condition | Intervention | Phase |
---|---|---|
Pain |
Drug: Lidocaine Drug: 24% Sucrose Solution |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Evaluation of Topical Liposomal Lidocaine and Oral Sucrose for Treatment of Pain in Newborn Infants Undergoing Venipuncture: A Randomized Controlled Trial |
Estimated Enrollment: | 330 |
Study Start Date: | August 2007 |
Estimated Study Completion Date: | June 2009 |
Estimated Primary Completion Date: | February 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Active Comparator
This group will receive lidocaine and sucrose placebo (water).
|
Drug: Lidocaine
1g of liposomal lidocaine will be administered 30-40 minutes prior to venipuncture and occluded by a dressing.
|
2: Active Comparator
This group will receive lidocaine placebo and sucrose.
|
Drug: 24% Sucrose Solution
2ml of 24% sucrose will be administered 2 minutes prior to venipuncture
|
3: Active Comparator
This group will receive lidocaine and sucrose.
|
Drug: Lidocaine
1g of liposomal lidocaine will be administered 30-40 minutes prior to venipuncture and occluded by a dressing.
Drug: 24% Sucrose Solution
2ml of 24% sucrose will be administered 2 minutes prior to venipuncture
|
Despite the fact that modern medical practice is greatly advanced, pain is inflicted on all Canadian newborn infants in the first days and months of life from blood tests, injections and cannulations designed to prevent, diagnose or manage medical conditions. Procedural pain in newborn infants is a significant burden to infants, their parents, healthcare workers, and society at large.
This study proposes a large randomized controlled trial to determine the optimal analgesic regimen for procedural pain using methods that can be easily implemented in clinical practice. We will study liposomal lidocaine cream and sucrose oral liquid, used alone, or together, to manage procedural pain. Liposomal lidocaine is a relatively new anaesthetic formulation ideally suited for young infants due to the established role of lidocaine in neonatal clinical medicine. Sucrose (sugar water) reduces pain responses and is promoted in consensus guidelines developed by pain experts. However, it is perceived by many front-line clinicians to be simply a comforting agent rather than a true analgesic. Studying liposomal lidocaine and sucrose together is important since the combination may prove superior to either agent alone, and may even prevent or abolish pain from clinical procedures.
Ages Eligible for Study: | up to 7 Days |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Anna Taddio, PhD | 416-813-6235 | anna.taddio@sickkids.ca |
Canada, Ontario | |
The Hospital for Sick Children | Recruiting |
Toronto, Ontario, Canada, M5G 1X8 | |
Contact: Anna Taddio, PhD 416 813 6235 anna.taddio@sickkids.ca | |
Principal Investigator: Anna Taddio, PhD | |
Sub-Investigator: Gideon Koren, MD | |
Sub-Investigator: Derek Stephens, MSc | |
Mount Sinai Hospital | Recruiting |
Toronto, Ontario, Canada, M5G 1X5 | |
Contact: Vibhuti Shah, MD 416 586 4816 vshah@mtsinai.on.ca | |
Principal Investigator: Vibhuti Shah, MD | |
Sub-Investigator: Joel Katz, PhD |
Principal Investigator: | Anna Taddio, PhD | The Hospital for Sick Children, Toronto Canada |
Responsible Party: | The Hospital for Sick Children ( Anna Taddio/Principal Investigator ) |
Study ID Numbers: | 1000010747 |
Study First Received: | August 20, 2007 |
Last Updated: | May 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00519207 |
Health Authority: | Canada: Health Canada |
pediatrics pain infants newborn screening |
venipuncture lidocaine sucrose |
Lidocaine Pain |
Sensory System Agents Therapeutic Uses Physiological Effects of Drugs Central Nervous System Depressants Anesthetics Cardiovascular Agents |
Anti-Arrhythmia Agents Peripheral Nervous System Agents Central Nervous System Agents Pharmacologic Actions Anesthetics, Local |